Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Prostate Cancer |
Free Subscription
1 AJR Am J Roentgenol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Prostate Cancer is free of charge.
Beyond the AJR: Increased Use of Prostate MRI Before Biopsy Reduces Biopsy
Frequency Without Compromising Detection of Aggressive Cancer.
AJR Am J Roentgenol. 2023 Oct 25. doi: 10.2214/AJR.23.30407.
PubMed
Radical prostatectomy cancer grade and percentage of Gleason pattern 4 estimated
by global vs individual tumor grading correlate differently with the risk of
biochemical recurrence in Grade Group 2 and 3 cancers.
Am J Clin Pathol. 2024;162:51-61.
PubMed
Abstract available
Artificial intelligence for detection of prostate cancer in biopsies during
active surveillance.
BJU Int. 2024 Jul 4. doi: 10.1111/bju.16456.
PubMed
Abstract available
Enhancing circulatory myokines and extracellular vesicle uptake with targeted
exercise in patients with prostate cancer (the MYEX trial): a single-group
crossover study.
BMC Cancer. 2024;24:784.
PubMed
Abstract available
Seminal Papers in Urology: Darolutamide and survival in metastatic,
hormone-sensitive prostate cancer.
BMC Urol. 2024;24:135.
PubMed
Abstract available
Relationship between prostate-specific antigen, alkaline phosphatase levels, and
time-to-tumor shrinkage: understanding the progression of prostate cancer in a
longitudinal study.
BMC Urol. 2024;24:137.
PubMed
Abstract available
In silico exploration of anti-prostate cancer compounds from differential
expressed genes.
BMC Urol. 2024;24:138.
PubMed
Abstract available
Comparative analysis of genetic risk scores for predicting biochemical recurrence
in prostate cancer patients after radical prostatectomy.
BMC Urol. 2024;24:136.
PubMed
Abstract available
DNA ploidy and PTEN as biomarkers for predicting aggressive disease in prostate
cancer patients under active surveillance.
Br J Cancer. 2024 Jul 3. doi: 10.1038/s41416-024-02780.
PubMed
Abstract available
Epidemiology, treatment patterns, and clinical outcomes in de novo
oligometastatic hormone-sensitive prostate cancer.
Cancer. 2024 Jul 1. doi: 10.1002/cncr.35466.
PubMed
Abstract available
Novel hormone is safe and effective in men receiving radiotherapy for prostate
cancer.
Cancer. 2024;130:2408.
PubMed
MRI-guided in-bore biopsy of the prostate - defining the optimal number of cores
needed.
Cancer Imaging. 2024;24:81.
PubMed
Abstract available
[(68)Ga]Ga?PSMA?617 PET-based radiomics model to identify candidates for active
surveillance amongst patients with GGG 1-2 prostate cancer at biopsy.
Cancer Imaging. 2024;24:86.
PubMed
Abstract available
Binding of interleukin-1 receptor antagonist to cholinergic receptor muscarinic 4
promotes immunosuppression and neuroendocrine differentiation in prostate cancer.
Cancer Lett. 2024 Jun 28:217090. doi: 10.1016/j.canlet.2024.217090.
PubMed
Abstract available
Asparagine Dependency is a Targetable Metabolic Vulnerability in TP53-Altered
Castration-Resistant Prostate Cancer.
Cancer Res. 2024 Jul 3. doi: 10.1158/0008-5472.CAN-23-2910.
PubMed
Abstract available
Microsatellite Instability, Tumor Mutational Burden, and Response to Immune
Checkpoint Blockade in Patients with Prostate Cancer.
Clin Cancer Res. 2024 Jul 1. doi: 10.1158/1078-0432.CCR-23-3403.
PubMed
Abstract available
Prostate cancer risk assessment and avoidance of prostate biopsies using fully
automatic deep learning in prostate MRI: comparison to PI-RADS and integration
with clinical data in nomograms.
Eur Radiol. 2024 Jul 2. doi: 10.1007/s00330-024-10818.
PubMed
Abstract available
The role of lipidic balance on erectile dysfunction in prostate cancer patients
undergoing robotic surgery.
Int J Urol. 2024 Jul 3. doi: 10.1111/iju.15516.
PubMed
Abstract available
Assessing Response to PSMA Radiopharmaceutical Therapies with Single SPECT
Imaging at 24 Hours After Injection.
J Nucl Med. 2024 May 9:jnumed.123.267208. doi: 10.2967/jnumed.123.267208.
PubMed
Abstract available
Deescalated (225)Ac-PSMA-617 Versus (177)Lu/(225)Ac-PSMA-617 Cocktail Therapy: A
Single-Center Retrospective Analysis of 233 Patients.
J Nucl Med. 2024;65:1057-1063.
PubMed
Abstract available
Dosimetry of [(177)Lu]Lu-PSMA-Targeted Radiopharmaceutical Therapies in Patients
with Prostate Cancer: A Comparative Systematic Review and Metaanalysis.
J Nucl Med. 2024 Jul 3:jnumed.124.267452. doi: 10.2967/jnumed.124.267452.
PubMed
Abstract available
PSA Stratification for Predicting Advanced Prostate Cancer Events in Men
Approaching Age-Limits for Recommended Screening.
J Urol. 2024 Jul 5:101097JU0000000000004138. doi: 10.1097/JU.0000000000004138.
PubMed
Abstract available
Using multi-label ensemble CNN classifiers to mitigate labelling inconsistencies
in patch-level Gleason grading.
PLoS One. 2024;19:e0304847.
PubMed
Abstract available
Design and evaluation of a pneumatic actuation unit for a wasp-inspired
self-propelled needle.
PLoS One. 2024;19:e0306411.
PubMed
Abstract available
Single-cell analysis of treatment-resistant prostate cancer: Implications of cell
state changes for cell surface antigen-targeted therapies.
Proc Natl Acad Sci U S A. 2024;121:e2322203121.
PubMed
Abstract available
Discovery of PSMA in the prostate of the common marmoset (Callithrix jacchus).
Prostate. 2024;84:1086-1088.
PubMed
Abstract available
Morphologic patterns observed in prostate biopsy cases with discrepant grade
group and molecular risk classification.
Prostate. 2024;84:1076-1085.
PubMed
Abstract available
Thank you for your interest in scientific medicine.